Related Experiment Video

Updated: Apr 17, 2026

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior
06:38

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Published on: June 9, 2020

5.4K

Pedestrian deaths in children--potential for prevention

K Hamilton, W Macken, C McGarvey

    Irish Medical Journal
    |February 24, 2015
    PubMed

    Insights

    Child pedestrian fatalities are preventable, with non-traffic incidents like vehicle rollovers being a significant concern. Prevention strategies should focus on modifying behavioral, social, and environmental risk factors.

    Area of Science:

    • Pediatric Safety
    • Public Health
    • Injury Prevention

    Background:

    • Child pedestrian fatalities represent a critical public health issue.
    • Understanding the circumstances surrounding these deaths is essential for developing effective interventions.

    Purpose of the Study:

    • To analyze child pedestrian fatalities recorded in the National Paediatric Mortality Database from 2006-2011.
    • To categorize fatalities into traffic and non-traffic related incidents and identify key risk factors.

    Main Methods:

    • Review of the National Paediatric Mortality Database for child pedestrian deaths between January 1, 2006, and December 31, 2011.
    • Categorization of fatalities into traffic and non-traffic related causes.
    • Analysis of demographic, temporal, and situational factors associated with pedestrian deaths.

    Main Results:

    • A total of 45 child pedestrian fatalities were identified.
    • Non-traffic related deaths (42%) were significant, with low-speed vehicle rollovers in driveways accounting for a substantial portion (28% of total deaths).
    • Deaths showed a male preponderance (62%), a weekend trend (49%), an evening peak (35%), and a summer peak (44%). The 1-4 year age group was most affected (53%).

    Conclusions:

    • Child pedestrian fatalities are largely preventable through targeted interventions.
    • Emphasis on addressing non-traffic related incidents, particularly low-speed vehicle rollovers in residential areas, is crucial.
    • Modifying behavioral, social, and environmental risk factors is key to reducing child pedestrian deaths.

    More Related Videos

    Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children04:55

    Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

    Published on: September 11, 2018

    11.4K
    Physical Activity Measurement in Children Accepting Table Tennis Training06:51

    Physical Activity Measurement in Children Accepting Table Tennis Training

    Published on: July 27, 2022

    2.6K

    Related Concept Videos

    Preventive Healthcare Services01:30

    Preventive Healthcare Services

    Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
    2.3K
    Levels of Health Promotion and Illness Prevention01:26

    Levels of Health Promotion and Illness Prevention

    Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
    In primary prevention, actions taken before disease onset prevent the disease from...
    16.0K
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    507
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    362
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    391
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    904